Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26310718 | 1.00 | NAAA (0.44) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25610907 | 1.00 | NAAA (0.44) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25610819 | 1.00 | NAAA (0.44) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25610929 | 0.98 | CA2 (0.45) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL26383988 | 0.98 | CA2 (0.45) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25610825 | 0.98 | NAAA (0.46) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25610830 | 0.98 | NAAA (0.46) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL27269261 | 0.95 | NAAA (0.43) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL25989933 | 0.94 | NAAA (0.42) | NAAATHRATHRBCA2EPHX1 | |
| SCHEMBL27323112 | 0.94 | NAAA (0.42) | NAAATHRATHRBCA2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024124143-A2 | HSC TARGETED LNP FOR DELIVERY OF PRO-APOPTOTIC MRNA AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024112882-A1 | TARGETED DELIVERY OF GENE EDITING CONSTRUCTS AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024086614-A2 | TARGETED LNP-MRNA WITH MINIMAL OFF-TARGET EXPRESSION AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024083345-A1 | METHODS AND USES ASSOCIATED WITH LIQUID COMPOSITIONS | BioNTech SE (DE) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024056856-A1 | SYSTEMS AND COMPOSITIONS COMPRISING TRANS-AMPLIFYING RNA VECTORS WITH MIRNA | BioNTech SE (DE) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023250375-A1 | CIRCULAR RNA ENCODING CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA | ORNA THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023213783-A1 | REPLICON COMPOSITIONS AND METHODS OF USING SAME FOR THE TREATMENT OF DISEASES | BioNTech SE (DE) | 2023-11-09 | — | — | WO | disclosed |
| EP-3959195-B1 | THIOESTER CATIONIC LIPIDS | TRANSLATE BIO INC (US) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023166099-A1 | RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | BioNTech SE (DE) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023073190-A9 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023073190-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2023-05-04 | — | — | WO | disclosed |
| WO-2022101470-A1 | LNP COMPOSITIONS COMPRISING RNA AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2022-05-19 | — | — | WO | disclosed |
| WO-2022101471-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING LIPID NANOPARTICLES AND MRNA, AND METHODS FOR PREPARING AND STORING THE SAME | BioNTech SE (DE) | 2022-05-19 | — | — | WO | disclosed |
| EP-3896164-A1 | POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE | ModernaTX, Inc. (US) | 2021-10-20 | — | — | EP | disclosed |
| WO-2017201328-A1 | POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | disclosed |